JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

Akt

B1371 Miltefosine

Target: PI3K

Summary: PI3K/Akt inhibitor

≥10.2 mg/mL
A9904 AKT/mTOR Set I

Summary: For inhibiting AKT/mTOR
A8619 TIC10

Summary: Potent Akt/ERK inhibitor
A8618 Palomid 529

Summary: PI3K/Akt/mTOR inhibitor

insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
A8617 CCT128930 HCl

Target: Akt

Summary: AKT inhibitor

insoluble in H2O; ≥17.1 mg/mL
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8541 Triciribine
5 Citation

Summary: Akt inhibitor,highly selective

insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL
A8309 Perifosine
1 Citation

Target: Akt

Summary: Akt inhibitor
A5884 PHT-427

Summary: Akt and PDPK1 inhibitor

insoluble in H2O; ≥20.5 mg/mL
A5653 AT7867

Target: Akt|PKA|p70 rsk

Summary: Akt1/2/3 and p70S6K/PKA inhibitor

≥16.9 mg/mL